Genomic polymorphism of human papillomavirus type 52 predisposes toward persistent infection in sexually active women.

@article{Aho2004GenomicPO,
  title={Genomic polymorphism of human papillomavirus type 52 predisposes toward persistent infection in sexually active women.},
  author={Jos{\'e}phine Aho and Catherine A. Hankins and C{\'e}cile L Tremblay and Pierre Forest and Karina Pourreaux and Fabrice Rouah and François Coutl{\'e}e},
  journal={The Journal of infectious diseases},
  year={2004},
  volume={190 1},
  pages={
          46-52
        }
}
We investigated the role of human papillomavirus (HPV) type 52 polymorphism in the persistence of HPV infection, which is a predictor for cervical lesions. Cervical samples obtained at 6-month intervals were tested for HPV-52 in 1055 women; 41, 12, and 58 women had persistent, transient, and unclassified HPV-52 infections, respectively. HPV-52 isolates were analyzed by polymerase chain-reaction sequencing of the long control region (LCR), E6, and E7 genes. Although age (odds ratio [OR], 0.90… 
View on PubMed
academic.oup.com
43 Citations
Highly Influential Citations
1
Background Citations
9
Results Citations
4

Tables from this paper

43 Citations

Citation Type

Citation Type

Human papillomavirus type 56 polymorphism in Canadian women with and without cervical lesions.
Unique variants of human papillomavirus genotypes 52 and 58 and risk of cervical neoplasia
TLDR
Frequency distributions of HPV 52 and 58 variants in Taiwan were different from those in European and American populations, and the association between C variant of HPV52 and prevalence of cervical neoplasia needs further validation.
Human papillomavirus type 52 polymorphism and high‐grade lesions of the uterine cervix
TLDR
It is indicated that HPV52 polymorphism influences risk of CIN‐2,3 and possibly invasive cancer andpossibly invasive cancer in Canadian women.
Viral polymorphism in human papillomavirus types 33 and 35 and persistent and transient infection in the genital tract of women.
TLDR
HPV-33 and -35 polymorphism was different between types and was associated with persistence of HPV infection, whereas age and HIV infection/CD4 cell count status were not significantlyassociated with persistence.
Polymorphism of the L1 capsid gene and persistence of human papillomavirus type 52 infection in women at high risk or infected by HIV.
TLDR
HPV-52 polymorphism was described and assessed and L1 capsid variations were not associated with persistence, suggesting L1 variations are unlikely to predispose to HPV-52 persistence and thus do not help to identify women at greater risk for HSILs.
Human papillomavirus type 33 polymorphisms and high-grade squamous intraepithelial lesions of the uterine cervix.
TLDR
Intratypic LCR variants of HPV-33 seem to vary geographically and to differ with respect to their oncogenic potential.
Variants of human papillomavirus type 16 predispose toward persistent infection.
TLDR
It was found that the variants T178G, T350G and A442C in the E6 gene, as well as C3158A and G3248A variants in theE2 gene were associated with persistent HPV16 infection, and no link was observed between E7 variants and persistent viral infection.
Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis.
TLDR
HPV persistence was consistently and strongly associated with high-grade cervical intraepithelial neoplasia and CIN2-3/HSIL+, despite wide variation in definitions and study methods.
Polymorphism of human papillomavirus type 31 isolates infecting the genital tract of HIV‐seropositive and HIV‐seronegative women at risk for HIV infection
TLDR
The genomic polymorphism of high‐risk human papillomavirus type 31 in 79 women by PCR‐sequencing of the long control region (LCR), E6 and E7 was more polymorphic than oncogenes and was associated with ethnicity.
Long-Term Follow-Up of HPV16-Positive Women: Persistence of the Same Genetic Variant and Low Prevalence of Variant Co-Infections
TLDR
The prevalence, persistence and association with cervical intraepithelial neoplasia of different HPV16 variants is studied, using cervical swabs and whole tissue sections of biopsies from 548 women in the placebo group of a HPV16/18 vaccine trial.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 26 REFERENCES
Molecular analysis of human papillomavirus type 52 isolates detected in the genital tract of human immunodeficiency virus-seropositive and -seronegative women.
TLDR
The genetic diversity of HPV-52 should facilitate the investigation of the role of genomic variations in cervical disease, and was an independent predictor for HIV infection when controlling for age and sexual activity.
Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia.
TLDR
If confirmed in other populations, measurement of intratypic variation of HPV-16 and -18 has the potential to serve as an ancillary tool in cervical cancer screening.
Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer.
TLDR
Acquisition and clearance of cervical human papillomavirus infection were analyzed among 1425 low-income women attending a maternal and child health program in São Paulo, Brazil, and nononcogenic-type infections lasted longer among younger (<35 years old) than in older women.
Human papillomavirus type 16 variants and risk of cervical cancer.
TLDR
This study conducted a prevalent case– control study within a 10 000-woman, population-based cohort in Costa Rica to examine the association between HPV16 variants and cervical neoplasia, and has the advantage of having been conducted in a highly admixed population.
Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia.
TLDR
It is suggested that the risk of developing CIN 2-3 is not the same with all variants of HPV16 and that nonprototype-like variants confer a greater risk compared with prototype- like variants.
Association of human papillomavirus type 58 variant with the risk of cervical cancer.
TLDR
HPV type 58 variants carrying E7 T20I/G63S substitutions may be associated with an increased risk for cervical cancer, especially among HPV58-positive women.
Increased risk of high-grade anal neoplasia associated with a human papillomavirus type 16 E6 sequence variant.
TLDR
An elevated risk for high-grade anal squamous intraepithelial lesions was associated with infection by G131 variants, compared with the prototype strain, and further evidence for HPV strain variation as a factor in determining the natural history of anogenital neoplasia is provided.
Detection of Human Papillomavirus Type 16 DNA in Consecutive Genital Samples Does Not Always Represent Persistent Infection as Determined by Molecular Variant Analysis
TLDR
This study undertook a study using PCR–single-strand conformation polymorphism (SSCP) analysis and sequencing of PCR products (PCR-sequencing) to determine if consecutive HPV-16-positive samples contained the same HPV-15 variant, suggesting persistent infection.
Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia.
TLDR
A strong relationship exists between persistent HPV infections and SIL incidence, particularly for HPV types 16 and 18, which is believed to be the central cause of cervical cancer.
Risk of anal carcinoma in situ in relation to human papillomavirus type 16 variants.
TLDR
Neither detection of HPV16 DNA at high levels nor detection ofHPV16 DNA for a prolonged period, factors that were previously demonstrated to be associated with risk of high-grade anal squamous intraepithelial neoplasia, was significantly associated with HPV16 NPL variants.
...
1
2
3
...